News from rosetta genomics ltd. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 15, 2012, 09:15 ET

Rosetta Genomics Added to Ocean Tomo 300 Patent Index

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced the...

Nov 08, 2012, 09:00 ET

Rosetta Genomics to Appoint Dr. Yitzhak Peterburg to its Board of Directors

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced summoning of a...

Nov 06, 2012, 09:00 ET

New York State Grants Final Approval for miRview® lung; Expands Access for Rosetta Genomics' microRNA Diagnostic for Identification of Four Major Subtypes of Lung Cancer

 Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic assays, announces that the New York...

Oct 02, 2012, 08:30 ET

Rosetta Genomics and Precision Therapeutics Announce U.S. Commercial Launch of miRview® mets2

Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, and Precision Therapeutics, Inc....

Aug 29, 2012, 12:00 ET

Rosetta Genomics Announces Exercise and Closing of Underwriter's Over-Allotment Option

 Rosetta Genomics Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced...

Aug 20, 2012, 09:00 ET

Rosetta Genomics Expands Management Team, Laboratory Capacities and Commercial Operations

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced the completion...

Aug 13, 2012, 09:00 ET

Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that Frost...

Aug 08, 2012, 11:42 ET

Rosetta Genomics Announces Closing of Public Offering of 5.5 Million Ordinary Shares

 Rosetta Genomics Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced...

Jul 24, 2012, 09:00 ET

Rosetta Genomics and Precision Therapeutics Enter into Co-Marketing Agreement for miRview® mets(2) Assay

 Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic assays, announced today that it...

Jun 27, 2012, 18:39 ET

CORRECTION: LHA Life Sciences & Medical Technologies Virtual Conference

 Rosetta Genomics Ltd. (NasdaqGM: ROSG) will not participate in the following virtual conference:   What:   ...

Jun 22, 2012, 09:00 ET

Rosetta Genomics Pays Off Secured Loan and Reclaims Unencumbered Rights to All Assets

 Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic assays, today announced that the...

Nov 04, 2011, 08:30 ET

Study Published in World Journal of Gastroenterology Shows Potential for microRNAs to Predict Gastric Cancer Recurrence

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that results from a...

Oct 19, 2011, 18:09 ET

Rosetta Genomics Initiates Closing of Private Placement

Rosetta Genomics, Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced that...

Oct 13, 2011, 09:00 ET

Rosetta Genomics to Raise $1.9 Million in Private Placement

Rosetta Genomics, Ltd. ("Rosetta") (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced it has...

Oct 11, 2011, 09:00 ET

Rosetta Genomics Restructures to Reduce Operating Expenses and Focus on Commercial Opportunities

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, today announced a corporate...

Oct 11, 2011, 08:01 ET

Rosetta Genomics Announces Exclusive License with Avatao Biotech for Distribution of miRview Tests in China

 Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced that it has...

Sep 08, 2011, 08:00 ET

Rosetta Genomics to Present at Rodman & Renshaw 13th Annual Global Investment Conference

 Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced today...

Jul 06, 2011, 08:01 ET

Rosetta Genomics Announces One-For-Four Reverse Stock Split

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, today announced the...

Jun 28, 2011, 10:12 ET

Rosetta Genomics and UC Davis Researchers to Develop and Validate microRNA Biomarker to Predict Response to Neoadjuvant Chemotherapy in Bladder Cancer

Rosetta Genomics (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, announces it has entered into a...

May 09, 2011, 08:33 ET

Rosetta Genomics Announces Issuance of Additional U.S. Patent

Rosetta Genomics (NASDAQ: ROSG) today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 7,943,745,...